Purification of recombinant human basic fibroblast growth factor
stability of selective sorbents under cleaning in place conditions
- authored by
- F. Birger Anspach, Henning Spille, Ursula Rinas
- Abstract
Human basic fibroblast growth factor (bFGF) was produced from recombinant Escherichia coli by high-cell-density cultivation. In order to develop a purification strategy for large-scale purification, chromatographic sorbents with different anionic functional groups were compared in terms of selectivity for bFGF and stability under cleaning in place (CIP) conditions. Heparin-Sepharose CL-6B, Fractogel EMD-SO3- 650 (S) and SP-Sepharose (high performance) were found suitable for this purpose with decreasing selectivity in that order. Each sorbent was treated eight times under CIP conditions employing both 0.2 and 1.0 M NaOH, in order to study modifications of these sorbents. Heparin-Sepharose displayed more than 50% loss of capacity after the first CIP treatment and decreasing selectivity with each cycle. Both cation exchangers displayed almost constant results regarding selectivity and capacity. The Fractogel EMD-SO3- exhibited only slightly lower selectivity for bFGF than Heparin-Sepharose and the highest capacity of all sorbents tested. Agglomeration of bFGF at low salt concentrations was a serious problem. By direct application of pooled fractions from Fractogel EMD-SO3- onto Heparin-Sepharose a highly pure product was obtained; however, the recovery after Heparin-Sepharose was only 30%.
- External Organisation(s)
-
Helmholtz Centre for Infection Research (HZI)
- Type
- Article
- Journal
- Journal of Chromatography A
- Volume
- 711
- Pages
- 129-139
- No. of pages
- 11
- ISSN
- 0021-9673
- Publication date
- 08.09.1995
- Publication status
- Published
- Peer reviewed
- Yes
- ASJC Scopus subject areas
- Analytical Chemistry, Biochemistry, Organic Chemistry
- Electronic version(s)
-
https://doi.org/10.1016/0021-9673(95)00102-S (Access:
Closed)